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University of Melbourne, the first nurse invited speaker 
was Linda White from the MD Anderson in Texas. White 
worked as a prevention and early detection specialist at the 
Anderson and among other roles, performed colposcopies. 
Her plenary talk at the meeting, sandwiched between talks 
on oncogenes, sparked heated debate on whether nurses 
here could aspire to such roles. One gynaecology specialist 
was adamant that Australian nurses would never be able to 
perform at this level. 
Where then is cancer nursing on the international stage in 
the year 2013? From a professional perspective, nurses 
from Australia have played a significant role in shaping 
the development of the International Society of Nurses 
in Cancer Care (ISNCC). The previous board of ISNCC 
had four nurses from Australia out of 14 board members, 
including the President and Treasurer. From a development 
perspective, the work of EdCaN and the framework it 
produced is being used by many nurses around the world 
as they shape their own developments. In research, our 
cancer nursing intervention research is among the best in 
the world and is published in high impact journals, in both 
nursing and medicine. The early inspiration for improving 
practice and undertaking research for many nurses was 
attendance at a COSA meeting. While our development 
often paralleled what was happening for cancer nursing in 
other countries, it was always given local context by the 
important inter-professional dialogue that COSA enabled.   
The future for cancer nursing
Today, cancer nursing is facing new pressures to adapt and 
reform in response the growing demand for cancer services, 
the recognition of cancer as a chronic disease, the need for 
accelerated transfer of knowledge into practice, and growing 
fiscal challenges. Like other health professionals, cancer 
nurses must respond by developing and adopting new 
approaches to care. For example, adopting the principles 
of risk stratification will help to ensure the right care gets 
to the right person at the right time. Care coordination is 
also a critical component of cancer care in Australia as an 
increasing number of patients receive care across different 
facilities, including across public/private and metro/rural 
settings. A shift to supported self-management approaches 
is also required to accommodate the chronic nature of 
cancer and its effects, and the reality that most people with 
cancer experience these treatment effects in their homes. 
A recent report by Health Workforce Australia highlighted 
that new advanced nursing roles established in the US and 
UK have demonstrated potential to increase efficiency and 
accessibility of cancer care.10 While there are numerous 
barriers to acceptance and challenges in implementation 
of such roles,10 the redesign of traditional roles and a 
greater blurring of practice boundaries will present new 
opportunities to achieve better patient outcomes. 
Ongoing work is required to ensure people affected by 
cancer receive the best possible care from nurses, no matter 
what their social, demographic or clinical circumstance. 
Indeed, a recent report by the Institute of Medicine (IOM) 
on the future of nursing confirmed that by virtue of its 
numbers and adaptive capacity, the nursing profession 
has the potential to effect wide-reaching changes in the 
health care system.1 The IOM report calls for nurses to be 
enabled to practice to the full extent of their education and 
training and for clearer pathways with seamless academic 
progression and associated credentialing to ensure quality 
care. Importantly, the IOM report calls for nurses to be full 
partners with physicians and other health professionals in 
redesigning health care. COSA and the opportunities such 
a society presents for multidisciplinary care, mean that 
cancer nurses in Australia are well placed to respond to 
this call to action.  
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In Australia, the history of the transition from geographically 
and clinically limited hospice services to palliative care 
services over the past 40 years has paralleled closely the 
development of sub-specialist oncology services. Indeed, 
much of the impetus has come directly from leaders in 
oncology who recognised and acted to address patients’ 
unmet needs in a better and more responsive way.1,2
By the early 1970s, three major providers accounted for 
most hospice services in Australia: the Little Company 
of Mary; Sisters of Charity; and the Deaconess Society. 
The model of care was built around care for the dying 
and indeed, as recently as 1982, a neon sign outside one 
institution read ‘Hospice for the Poor and Dying’. This was 
care in a tradition that had arisen in the middle ages to 
ensure that people at the margins (and the dying still face 
such marginalisation) were provided with care and shelter, 
often for extended periods of time. At the same time, 
nursing home bed numbers were expanding and, similar 
to hospices, tended also to have relatively long lengths of 
stay. Neither group of institutions had discharge policies, 
with care provided until death supervened.
The leadership shown internationally by people such as 
Vittorio Ventafridda (Italy), Cecily Saunders (England) and 
Balfour Mount (Canada) led to an undeniable shift in care 
for people with advanced illness. Providing quality health 
care for the dying that addressed physical, emotional, 
existential, social and sexual needs became a focus of 
active needs-based care, rather than simply closeting 
people away once death became inevitable. Australia, as 
one can argue often happens in health care, took the best 
of the international models and philosophies and adapted 
them to the local health and social systems. No single 
model could adapt perfectly to the manifest differences in 
health system design, funding nor geography. This allowed 
an eclecticism that has served well.
Development of palliative care
A watershed for the early evolution of palliative care in 
this country was the commissioning of a report by the 
Anti-Cancer Council of Victoria on care of the dying in 
1983.3 This was a report whose recommendations have 
echoed through the subsequent three decades – there 
was a perceived need to have services provided at a 
geographical level with a team led from, and integrated, 
with existing health services, given that this was where 
the population who were facing the end of their life could 
be identified currently. The report also indicated that 
building further freestanding hospices would not serve 
the target population well. The latter was a particularly 
salient recommendation, given that two of the country’s 
largest freestanding hospices would close within 20 years 
of this report in order to move to a model that provided 
much closer integration with existing health services. At 
least three others have seen fundamental changes, with a 
decreasing number of beds augmented by hospital liaison 
and community-based teams. Such evolution has not been 
without controversy, but it does speak strongly to the vision 
held by Ross Webster and his committee in 1983 as he 
looked to the future needs of the population.3
By the mid-1980s several states had palliative care position 
statements, strategic plans or direction statements.4 Given 
the time lines, and the paucity of services globally, this 
showed an extraordinary level of jurisdictional leadership. 
Every state had its champions, and the diverse backgrounds 
of these medical and nursing leaders have positioned 
palliative care well: oncology; primary care; anaesthetics and 
pain medicine; general medicine; geriatrics and psychiatry. 
The late 1980s saw four important steps that have shaped 
the ensuing quarter of a century: 
• Creation of the world’s first academic chair in palliative 
care at Flinders University in 1987 (reflecting similar 
appointments over the next decade at a number of 
institutions). 
• Formation of the Specialist Advisory Committee in 
Palliative Medicine by the Royal Australasian College 
of Physicians in 1988, which was the world’s first sub-
specialist training program in palliative medicine. 
• For the first time, the inclusion of identified funds for 
states and territories to use to develop palliative care 
services in the 1988 quinquennial Medicare agreement. 
• A meeting convened by the Medical Oncology Group 
of Australia in 1989 to help map the future direction of 
palliative care from the viewpoint of oncology services.5 
The Chair at Flinders University has evolved into a unit 
that delivers the largest distance education program in 
palliative care in the southern hemisphere and one of 
the biggest in the world, with 400 current post-graduate 
students, together with a niche program designed to 
provide affordable post-graduate education to clinicians in 
resource-poor countries spanning the Middle East to South 
East Asia. The department is now host to one of several 
productive research teams across the country, each of 
which has an international track record of leadership in their 
areas of expertise.
Abstract
In parallel with the rapid development of oncology in Australia, palliative and supportive care has evolved rapidly. The 
sponsorship for such development was largely generated by oncology services in response to unmet needs that were 
encountered daily. Development of state, territory and national strategies has mirrored the professional development 
in service delivery, education (of existing practitioners and tomorrow’s clinicians) and research. More recently, national 
programs are delivering better outcomes for palliative care patients and their families, world-leading clinical research, 
improved access to essential medications in the community and the ability to access quality evidence to inform 
practice and policy. These initiatives provide a valuable foundation for continuing to improve access to high quality 
clinical care wherever people live.     
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The Royal Australasian College of Physicians program 
allowed a direct path to subspecialisation that was gradually 
taken up. This was augmented in 2000 with the formation 
of a Chapter of Palliative Medicine within the college to 
facilitate lateral entry from other learned colleges. This has 
allowed a group of clinicians from a wide range of clinical 
backgrounds to undertake palliative medicine sub-specialty 
training and bring their diversity of skills to care for people 
at the end of life, reflecting the diversity of early clinical 
champions of palliative care in Australia and around the 
world. More recently a clinical diploma has been added to 
the program.6
Medical oncology
The 1989 meeting convened by Medical Oncology Group 
of Australia cemented the close relationship between 
oncology and palliative care, with most palliative care 
services still providing the majority of their clinical services to 
people with cancer and their families. This meeting occurred 
at a time when the philosophical underpinnings of palliative/
hospice care were still being hotly debated. The model in 
the UK was struggling to move beyond cancer, especially 
with the advent of AIDS, but also with the changing face 
of dying: chronic, complex, slowly progressive diseases 
leading inexorably to death.5 Australia’s policies from that 
time forward have not limited care by perceived prognosis 
(unlike the US), nor by diagnosis (unlike many charitably 
funded, freestanding services in the UK).  
A national strategy
The 1998 national census (State of the Nation) undertaken 
by the newly renamed Palliative Care Australia, was an 
important step in measuring the progress made in ensuring 
that people, wherever they lived, had access to palliative 
care.7 Participants were asked to record their activity over 
the same 24 hour period and the data collated. This was 
the first national view of what services were delivering, the 
patients being seen and the models of service delivery 
that had evolved over the previous two decades. Much 
of this local evolution was because of widely varying 
mechanisms for funding and widely varying commitment at 
the jurisdictional and local level for the provision of palliative 
care. The legacy of this is still felt in varying levels of service 
access, with some tertiary services still only providing 
nominal support for the vision laid out by Ross Webster in 
1983.3 
The census demonstrated, as expected, that cancer 
accounted for approximately 90% of all referrals to services, 
although again there was wide variation depending on a 
number of local factors as to the population served. Care 
was delivered in the community, in hospitals (consultative, 
direct care or both) or a number of free standing and 
co-located inpatient palliative care units.
The first national strategy was endorsed by all states and 
territories and the Commonwealth in 2000, and updated 
again with jurisdictional support in 2010. This document 
provided a real basis on which to build, for the first time, 
truly national initiatives with Commonwealth funds directed 
nationally, not just for jurisdictional projects. Fundamental 
principles included equity of access to high quality services 
underpinned by the best evidence available. There was 
a specific focus on improving community-based care, 
to which the Commonwealth has continued to provide 
resources. As part of this work, a review of research 
capability in palliative care was commissioned by the 
Commonwealth, which demonstrated few units with 
strong competitive track record or the requisite pipeline of 
researchers coming through.  
National programs that arose included improving:
• research capability
• education of the existing and the future workforce
• affordable community availability of key medications for 
symptom control
• quality of care delivered 
• access to the evidence to inform practice and policy. 
These programs have put Australia at the forefront of 
palliative care in the world. This program was conceived 
and delivered by Rita Evans in the Department of Health 
and Ageing through the National Palliative Care Program. 
Without her vision these programs could not have come 
to fruition. 
A variety of models of service delivery evolved. There was 
however, a key shift with the development of the National 
Palliative Care Strategy (2000), to which each state, 
territory and the Commonwealth became a signatory. 
This set the stage for investment by the Commonwealth 
directly in initiatives at a national level. This investment has 
been far-reaching, with each of the subsequent Medicare 
agreements providing funding in parallel with national 
initiatives. Much of this initial funding seeded new services, 
improving geographical coverage.
Research capability
In research, the Commonwealth invested in a specific 
program which included bursaries for research higher 
degrees at a masters and doctoral level, together with a 
number of seed grants that allowed researchers to establish 
a category 1 track record with a view to improving their 
access to competitive grants nationally. This program, in 
conjunction with the National Health and Medical Research 
Council, was a two way process, as it also encouraged the 
council to consider reviewers who had research expertise in 
palliative care.  The Commonwealth’s investment has been 
successful and, within a decade, palliative care has been 
gaining category 1 grants and completing these studies.8
Health workforce education
In education, the Palliative Care Curriculum program (www.
PCC4U.org) has developed and worked to disseminate the 
key undergraduate competencies for all health professionals 
irrespective of their discipline. The competencies include: 
individual attributes (empathy, compassion, caring and 
a non-judgmental approach); clinical skills (assessment, 
pathophysiology of dying, pharmacology); communication 
skills (active listening, reflection); and palliative care 
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principles (philosophy, multi-disciplinary care). The program 
has worked with universities to assimilate these handful 
of essential concepts into curricula.9 Uptake has been 
more likely if a curriculum is being rewritten and so the 
process of uptake will take time. Simultaneously, there 
have been funded opportunities for existing practitioners 
to learn or update their skills in palliative care; the Program 
of Experience in the Palliative Approach (PEPA) has seen 
a wide range of practitioners take the opportunity for 
attachments to services often within their referral network.  
Care and medications
The Palliative Care Clinical Studies Collaborative was 
a Commonwealth initiative whose genesis lay in the 
challenges of creating the first patient-defined section of the 
Pharmaceutical Benefits Scheme (PBS) in Australia. Until 
2004, all sections of the PBS had been defined only by the 
clinician who was entitled to write that prescription. Shifting 
specific sections to a patient-based focus has since been 
emulated in both paediatrics and Aboriginal and Torres 
Strait Islander health. The palliative care section of the PBS 
started with medications where indications were already 
registered with the Therapeutic Goods Administration 
and where there was sufficient evidence to support cost 
effectiveness for a Pharmaceutical Benefits Advisory 
Committee application. February 2004 saw this section 
established and it has grown consistently every year 
since. However, there were still a number of medications 
considered ‘essential’ by clinicians for symptom control 
in the community,10 for which there was not sufficient 
evidence for either registration or subsequent subsidy 
applications. As a result of this, the Palliative Care Clinical 
Studies Collaborative was established and is conducting 
nine phase III clinical trials to improve the evidence base. To 
date, more than 1000 participants have been randomised 
in these rigorously designed, adequately powered studies 
to improve the quality of care that is offered. The first of 
these studies has been reported.11
Improving the quality of care has been a focus of the 
Palliative Care Outcomes Collaborative.12 The collaborative 
is built around: point-of-care data collection; aggregated 
analysis of data nationally, at a jurisdictional level and by 
model of service delivery; and benchmarking across the 
country in order to highlight key areas where outcomes 
can be improved by better models of service delivery. 
Key success factors for the program include a focused 
dataset with direct clinical utility, timely feedback of results 
and trained quality improvement facilitators to work with 
services in order to improve each service’s own outcomes. 
To date, more than 15,000 patients are reported in each six 
monthly report, with clear evidence that the outcomes are 
improving over the 13 six-monthly periods so far reported 
(figure 1). More recently, this has been complemented 
with a National Standards Assessment Program. The 
program relies on self-report of process measures that 
are thought likely to influence the quality of care offered. 
Both of these programs are designed to improve care. 
Figure 1: Number of patients, episodes of care, phases (left 
y axis) and services (right y axis) reported nationally through 
the Palliative Care Outcomes Collaborative in six monthly 
time periods 2006-2012.
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Access to evidence 
Improving the access to evidence is crucial in palliative 
care. Given its universal nature, the palliative care literature 
is spread literally across hundreds of journals.13 This is a 
huge challenge for practitioners and researchers in the 
field. CareSearch was created by the Commonwealth 
to improve that access and uses a unique system of 
real time interrogation of PubMed in order to ensure 
currency, together with unique access to the grey literature 
(conference abstracts that have not been converted into 
peer-reviewed publication, government reports, theses 
and journals before being listed on Index Medicus). It 
has structured searches for more than 50 topics that are 
validated for sensitivity, specificity and accuracy. This has 
improved access both for clinicians and researchers to 
literature wherever it occurs in the body of knowledge in 
real time (and is a model now being adapted to Aboriginal 
health and primary care). 
Ultimately, is palliative care living up to the hopes and 
aspirations of those who championed the needs of people 
at the end of life? What would Australia’s early palliative care 
champions, Fred Gunz or Wally Moon say today? Almost 
every teaching hospital now has a palliative care team, 
but many still do not have outpatient clinics (especially 
co-located with the services that are most likely to refer 
to them), nor the ability to admit patients directly under 
their care. Some still fail to provide real access to support 
around the clock for the emergency department.14 In the 
community, the models of service delivery vary widely, and 
clearly some people do not yet have equitable access.15 
But there is now a national approach to many things that 
until recently have been piecemeal, and quality evidence 
that the care that is being provided is systematically 
improving, a claim that can be made by very few specialties 
at a national level. Access to palliative care has improved 
where there has been a focused investment in services, 
but the challenge of poor access persists where health 
services have failed to make the investment required to 
strengthen local palliative care. Given the documented level 
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Radiation treatment has evolved over the past 12 decades 
into a highly sophisticated, cost-effective cornerstone 
treatment for people with cancer. It adds significantly 
to the chance of cure for many people with cancer and 
can be very effective in helping relieve symptoms for 
those in whom cure is not possible. Since 1956, when 
linear accelerators (linacs) came into mainstream clinical 
use in Australia, radiotherapy technology has advanced 
greatly. This, accompanied by major advances in our 
understanding of the biology of cancer and radiobiology, 
and exploitation of the benefits of combined modality 
treatment with surgery and systemic therapies, has led to 
significant improvements in treatment outcomes.  Although 
we have described the developments separately, often 
we see advances in technology, biology and integration 
occurring simultaneously and scattered across the globe. 
The primary goal of radiation treatment delivery for cancer 
is, always has been and always will be to maximally 
treat cancer tissue and maximally spare normal tissue. 
This underlying philosophy has guided almost all of the 
developments in radiation oncology from the outset. The 
Radiotherapy - a leap forward in cancer 
care
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Abstract
Radiotherapy is a cornerstone of modern integrated cancer care. It combines the real human face of caring for 
people with cancer with extraordinary science and technology. Its history is rich and our modern specialty of radiation 
oncology is built on the shoulders of giants, both in technology and biology. It is a highly cost-effective treatment that 
stands proudly on a large and robust evidence base. Quality radiation treatment can add significantly to the chance 
of curing many people with cancer and remains an invaluable palliative treatment for others. About half of all cancer 
patients benefit from having radiotherapy, mostly through improved survival. The specialty and what it can bring to 
patients continues to evolve apace and the high quality of treatment delivery is critical to its success. 
of acute care service delivery that has palliative intent,16 this 
is a sadly short-sighted decision at the local level of several 
large hospitals and health services in Australia in 2013. 
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